Search Results - "Wrenger, S"
-
1
Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin
Published in Respiratory medicine (01-03-2019)“…Human blood monocytes are divided into populations based on the differential expression of CD14 and CD16 receptors: CD14 + CD16(classical),…”
Get full text
Journal Article -
2
Does heart surgery change the capacity of α1-antitrypsin to inhibit the ATP-induced release of monocytic interleukin-1β? A preliminary study
Published in International immunopharmacology (01-04-2020)“…•Patient α1-antitrypsin inhibits ATP-mediated release of monocytic interleukin-1β.•Heart surgery does not markedly reduce this activity of…”
Get full text
Journal Article -
3
Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV)
Published in FEBS letters (21-01-2000)“…Increased concentrations of procalcitonin (PCT) are found in the plasma of patients with thermal injury and in patients with sepsis and severe infection,…”
Get full text
Journal Article -
4
The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity
Published in Biological chemistry (01-07-2002)“…Activated T lymphocytes express high levels of dipeptidyl peptidase IV (DP IV)/CD26. Recent studies support the notion that DP IV may play an important role in…”
Get more information
Journal Article -
5
Alpha1-Antitrypsin Therapy Suppresses Acute Rejection in an Orthotopic Murine Lung Transplantation Model
Published in The Journal of heart and lung transplantation (01-04-2019)“…α1-antitrypsin (AAT) is an acute phase protein, major inhibitor of neutrophil proteases and considered as a regulatory protein of broad immune and inflammatory…”
Get full text
Journal Article -
6
-
7
Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses
Published in International journal of molecular sciences (27-01-2023)“…PiZZ (Glu342Lys) α1-antitrypsin deficiency (AATD) is characterized by intrahepatic AAT polymerization and is a risk factor for liver disease development in…”
Get full text
Journal Article -
8
Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients
Published in Journal of inflammation research (30-11-2020)“…Cumulating reports suggest that acute phase proteins (APPs) have diagnostic and prognostic value in different clinical conditions. Among others, APPs are…”
Get full text
Journal Article -
9
Attractin, a dipeptidyl peptidase IV/CD26-like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function
Published in Journal of leukocyte biology (01-09-2006)“…The ectoenzyme dipeptidyl peptidase IV (DP IV; CD26) was shown to play a crucial role in T cell activation. Several compounds inhibiting DP IV‐like activity…”
Get full text
Journal Article -
10
Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review)
Published in International journal of molecular medicine (01-07-1999)“…The CD26 antigen is identical with the cell surface ectopeptidase dipeptidyl peptidase IV (DP IV, EC 3.4.14.5). The post proline cleaving substrate specificity…”
Get more information
Journal Article -
11
Identification of extra- and intracellular alanyl aminopeptidases as new targets to modulate keratinocyte growth and differentiation
Published in Biochemical and biophysical research communications (03-09-2004)“…Aminopeptidase inhibitors strongly affect proliferation, differentiation, and function of immune cells and show therapeutic potential in inflammatory…”
Get full text
Journal Article -
12
Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function
Published in Frontiers in bioscience (01-05-2008)“…Investigations using inhibitors of dipeptidyl peptidase IV (DP IV) activities and DP IV-/- mice indicated an immunoregulatory role of DP IV that could not be…”
Get full text
Journal Article -
13
Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor
Published in The Journal of biological chemistry (21-07-2000)“…Using synthetic inhibitors, it has been shown that the ectopeptidase dipeptidyl peptidase IV (DP IV) (CD26) plays an important role in the activation and…”
Get full text
Journal Article -
14
CD26/DP IV in T cell activation and autoimmunity
Published in Advances in experimental medicine and biology (2006)Get more information
Journal Article -
15
Expression and Activity of Ectopeptidases in Fibrillating Human Atria
Published in Journal of molecular and cellular cardiology (01-06-2001)“…Recent studies have demonstrated that atrial fibrillation (AF) occurs in the presence of degenerative changes of atrial tissue. In contrast, bradykinin (BK)…”
Get full text
Journal Article -
16
The N-terminal Structure of HIV-1 Tat Is Required for Suppression of CD26-dependent T Cell Growth
Published in The Journal of biological chemistry (28-11-1997)“…Evidence exists that the human immunodeficiency virus-1 (HIV-1) transactivator Tat occurs extracellularly and is involved in the immunosuppression of…”
Get full text
Journal Article -
17
Down-regulation of T Cell Activation following Inhibition of Dipeptidyl Peptidase IV/CD26 by the N-terminal Part of the Thromboxane A2 Receptor
Published in The Journal of biological chemistry (21-07-2000)“…Using synthetic inhibitors, it has been shown that the ectopeptidase dipeptidyl peptidase IV (DP IV) (CD26) plays an important role in the activation and…”
Get full text
Journal Article -
18
Different modes of dipeptidyl peptidase IV (CD26) inhibition by oligopeptides derived from the N‐terminus of HIV‐1 Tat indicate at least two inhibitor binding sites
Published in European journal of biochemistry (01-05-2003)“…Dipeptidyl peptidase IV (DP IV, CD26) plays an essential role in the activation and proliferation of lymphocytes, which is shown by the immunosuppressive…”
Get full text
Journal Article -
19
-
20